Zsolt Párkányi

Title: Zsolt Párkányi: A Distinguished Inventor in Pharmaceutical Innovation

Introduction

Zsolt Párkányi, based in Budapest, Hungary, is a notable inventor with a strong background in pharmaceutical research and development. With a portfolio that includes three granted patents, he has made significant contributions to the field, particularly in the preparation of dronedarone, a compound used in the treatment of atrial fibrillation.

Latest Patents

Párkányi's latest inventions include a groundbreaking process for the preparation of dronedarone through N-butylation. This invention not only describes the compound of formula (II) and its pharmaceutically acceptable salts but also details novel processes for its preparation. The patent outlines the reaction of the compound of formula (II) with another compound (L-(CH)—CH(III)), where L is a leaving group, paving the way for isolating the product and optionally converting it into a pharmaceutically acceptable salt. Additionally, the invention introduces several innovative intermediary compounds along with their preparatory methods.

Career Highlights

Throughout his career, Zsolt Párkányi has worked with leading pharmaceutical companies, including Sanofi and Sanofi-Aventis. His experience at these prominent institutions has undoubtedly influenced his inventive output, allowing him to leverage advanced research techniques and commercial insights into his innovative practices.

Collaborations

In his professional journey, Párkányi has collaborated with several esteemed coworkers, including Zsolt Dombrády and Antal Friesz. These partnerships have likely facilitated knowledge exchange and enhanced the inventive processes that led to his successful patents.

Conclusion

Zsolt Párkányi stands out as a distinguished inventor in the pharmaceutical industry. His contributions, particularly in the development of dronedarone, exemplify the impact of innovation on healthcare. As he continues to advance his research and development efforts, the pharmaceutical field eagerly anticipates the future innovations he will bring forth.